CORRECTION: Pomerantz Law Firm Announces the Filing of a

NEW YORK, Dec. 19, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Friday, December 17th by Pomerantz LLP, please note that in...

Related Keywords

New York ,United States ,Nevada ,Paris ,France General ,France ,New Jersey ,Tel Aviv ,Israel ,China ,Chicago ,Illinois ,Los Angeles ,Abrahaml Pomerantz ,Johnf Thero ,Roberts Willoughby ,Karim Mikhail ,Stephen Alpher ,United States District Court ,Us Court ,Drug Administration ,District Court ,Company Senior Vice ,Exchange Commission ,Supreme Court ,Us Supreme Court ,Amarin Corporation ,Securities Exchange ,Securities Exchange Act ,Class Period ,Lead Plaintiff ,Abbreviated New Drug Applications ,Defendant John ,Chief Executive Officer ,Federal Circuit ,Middle East ,Defendant Thero ,Senior Vice President ,Pomerantz Llp ,Lass Action ,